These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5780119)

  • 41. Stimulation of phagocytic activity of neutrophilic granulocytes by sera of patients with solid tumors.
    Klostergaard J; Evans JT; Fonte GC; Lane WW; Laor Y; Klein E; Holtermann OA
    J Med; 1980; 11(1):49-63. PubMed ID: 6995548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of anti-Azotobacter antibodies in sera from tumor patients].
    Cifuentes de Castro L; García López JL; Palmeiro Troitiño R
    Rev Esp Oncol; 1982; 29(4):765-9. PubMed ID: 6821460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of blood protein levels between diabetic and non-diabetic patients with retinopathy.
    Gul A; Rahman MA
    J Coll Physicians Surg Pak; 2006 Jun; 16(6):408-11. PubMed ID: 16787618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cancerolytic properties of the blood serum of patients with malignant tumors treated with drugs].
    Poliak NR; Medvetskiĭ NF
    Vrach Delo; 1966 Apr; 4():144-5. PubMed ID: 5990536
    [No Abstract]   [Full Text] [Related]  

  • 45. [Supplementary notes on methods for the demonstration of pathognostically and diagnostically important erythrocyte changes].
    Linke A
    Z Arztl Fortbild (Jena); 1979 Apr; 73(7):347-8. PubMed ID: 463113
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the Hakim serum reaction].
    Alekseev VG; Zaiakina LN
    Vopr Onkol; 1967; 13(7):115. PubMed ID: 5598966
    [No Abstract]   [Full Text] [Related]  

  • 47. Demonstration that red blood cell slowing factor found in cancer serum by microelectrophoresis is an alpha1 component.
    ROTTINO A; ANGERS J; DOOL A
    Proc Soc Exp Biol Med; 1962 Dec; 111():699-701. PubMed ID: 13975417
    [No Abstract]   [Full Text] [Related]  

  • 48. [A serological reaction used in the physiopathological study of tumors. IV. Isolation of an active glycide fraction].
    Marzona M; Lovisetto P; Biarese V; Molfese G; Trenta N; Gaurini G
    Boll Soc Ital Biol Sper; 1973 Sep; 49(18):1048-50. PubMed ID: 4802119
    [No Abstract]   [Full Text] [Related]  

  • 49. [Modification of total blood proteins in malignant tumors before and after surgical and psychotherapeutic treatments].
    PRIVITERA A
    Riv Patol Clin; 1956 Feb; 11(2):80-91. PubMed ID: 13371273
    [No Abstract]   [Full Text] [Related]  

  • 50. [Aspecific immunobiological manifestations of the human organism in malignant tumors].
    USSEGLIO G; CALCIATI A; RADICA U
    Minerva Med; 1952 Jul; 43(57-58):89-96. PubMed ID: 12992761
    [No Abstract]   [Full Text] [Related]  

  • 51. Atypical monocytes in patients with malignant tumors.
    Chomet B; LaPorte J; McGrew EA
    Acta Cytol; 1966; 10(3):197-9. PubMed ID: 5227371
    [No Abstract]   [Full Text] [Related]  

  • 52. [Certain characteristics of the processes of disturbance of the structural resistance of serum proteins in malignant neoplasms].
    TKACH VK
    Biofizika; 1960; 5():398-403. PubMed ID: 13777094
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on the origin of serum mucoprotein production; studies pertaining to increased mucoprotein in malignant tumors.
    WADA T; OHARA H; SASAKI T; NAKAJIMA J; YACHI A
    Gan; 1957 Oct; 48(3):305-14. PubMed ID: 13501350
    [No Abstract]   [Full Text] [Related]  

  • 54. [Development of the capillary sampling system for the analysis of erythrocytes].
    Sasaki K; Shibata S
    Rinsho Byori; 1974 Oct; 22(10 Suppl):197. PubMed ID: 4475799
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma proteins in malignant disease.
    BRENNAN MJ; SIMPSON WL; BETANZOS G
    Postgrad Med; 1958 Jul; 24(1):36-42. PubMed ID: 13567200
    [No Abstract]   [Full Text] [Related]  

  • 56. Blood and blood products.
    NANCE M
    J Pharm Pharmacol; 1950 May; 2(5):273-85. PubMed ID: 15422517
    [No Abstract]   [Full Text] [Related]  

  • 57. Cancer cells in blood. Results of a simplified isolation technique.
    LONG L; JONASSON O; ROBERTS S; MCGRATH R; MCGREW E; COLE WH
    Arch Surg; 1960 Jun; 80():910-9. PubMed ID: 14418112
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of neoplastic and allied diseases on the concentrations of the plasma proteins.
    MIDER GB; ALLING EL; MORTON JJ
    Cancer; 1950 Jan; 3(1):56-65. PubMed ID: 15405681
    [No Abstract]   [Full Text] [Related]  

  • 59. [Specific inhibitors of the interaction of some serum proteins in malignant tumors. 3. Demonstration of the neutralizing effect of the non-hemoglobin fraction of erythrocytes on the inhibitors of sera from patients with tumors and its isolation].
    Suchan M
    Cas Lek Cesk; 1969 Jan; 108(3):81-4. PubMed ID: 5780119
    [No Abstract]   [Full Text] [Related]  

  • 60. [Specific inhibitory interactions of serum proteins in malignant tumors. I. Study of the relations and properties of active serum inhibitors].
    Suchan M
    Cas Lek Cesk; 1967 Dec; 106(49):1323-7. PubMed ID: 5595102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.